These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23872452)

  • 1. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes.
    Khademvatan S; Adibpour N; Eskandari A; Rezaee S; Hashemitabar M; Rahim F
    Exp Parasitol; 2013 Oct; 135(2):208-16. PubMed ID: 23872452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes.
    Savoia D; Scutera S; Raimondo S; Conti S; Magliani W; Polonelli L
    Exp Parasitol; 2006 Jul; 113(3):186-92. PubMed ID: 16487518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
    Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
    Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico and in vitro comparative activity of green tea components against Leishmania infantum.
    Khademvatan S; Eskandari K; Hazrati-Tappeh K; Rahim F; Foroutan M; Yousefi E; Asadi N
    J Glob Antimicrob Resist; 2019 Sep; 18():187-194. PubMed ID: 30797085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of scorpiand-like azamacrocycle derivatives in promastigotes and intracellular amastigotes of Leishmania infantum and Leishmania braziliensis.
    Marín C; Clares MP; Ramírez-Macías I; Blasco S; Olmo F; Soriano C; Verdejo B; Rosales MJ; Gomez-Herrera D; García-España E; Sánchez-Moreno M
    Eur J Med Chem; 2013 Apr; 62():466-77. PubMed ID: 23395967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes.
    Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA
    Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum.
    Adinehbeigi K; Razi Jalali MH; Shahriari A; Bahrami S
    Pathog Glob Health; 2017 Jun; 111(4):176-185. PubMed ID: 28385129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial activity evaluation of thiazolidine-2,4-dione against Leishmania infantum and Leishmania braziliensis.
    Neri FSM; Júnior DBC; Froes TQ; da Silva PBG; do Egito MS; Moreira POL; de Pilla Varotti F; Castilho MS; Teixeira-Neto RG; de Albuquerque JFC; Leite FHA
    Parasitol Res; 2020 Jul; 119(7):2263-2274. PubMed ID: 32462293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain.
    Carrió J; Riera C; Gállego M; Portús M
    Acta Trop; 2001 May; 79(2):179-83. PubMed ID: 11369311
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macías I; Olmo F; Sanz AM; Campayo L; Cano C; Yunta MJ
    J Antimicrob Chemother; 2012 Feb; 67(2):387-97. PubMed ID: 22127582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Library of Seleno-Compounds as Novel Agents against Leishmania Species.
    Martín-Montes Á; Plano D; Martín-Escolano R; Alcolea V; Díaz M; Pérez-Silanes S; Espuelas S; Moreno E; Marín C; Gutiérrez-Sánchez R; Sanmartín C; Sánchez-Moreno M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis.
    Garin YJ; Sulahian A; Gangneux JP; Derouin F
    Pathol Biol (Paris); 1997 Jan; 45(1):48-51. PubMed ID: 9097846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
    Borborema SE; Osso Junior JA; Andrade Junior HF; Nascimento Nd
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):196-203. PubMed ID: 27192589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum.
    Rosypal AC; Hall JE; Bakunova S; Patrick DA; Bakunov S; Stephens CE; Kumar A; Boykin DW; Tidwell RR
    Vet Parasitol; 2007 Apr; 145(3-4):207-16. PubMed ID: 17298866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani.
    Wert L; Alakurtti S; Corral MJ; Sánchez-Fortún S; Yli-Kauhaluoma J; Alunda JM
    J Antibiot (Tokyo); 2011 Jul; 64(7):475-81. PubMed ID: 21522160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoterpenic aldehydes as potential anti-Leishmania agents: activity of Cymbopogon citratus and citral on L. infantum, L. tropica and L. major.
    Machado M; Pires P; Dinis AM; Santos-Rosa M; Alves V; Salgueiro L; Cavaleiro C; Sousa MC
    Exp Parasitol; 2012 Mar; 130(3):223-31. PubMed ID: 22227102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
    Pujals G; Suñé-Negre JM; Pérez P; García E; Portus M; Tico JR; Miñarro M; Carrió J
    Parasitol Res; 2008 May; 102(6):1243-7. PubMed ID: 18278586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
    Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
    Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
    Morais-Teixeira Ed; Carvalho AS; Costa JC; Duarte SL; Mendonça JS; Boechat N; Rabello A
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):358-62. PubMed ID: 18660990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5'-(3'-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study.
    Dardari Z; Lemrani M; Bahloul A; Sebban A; Hassar M; Kitane S; Berrada M; Boudouma M
    Farmaco; 2004 Mar; 59(3):195-9. PubMed ID: 14987982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.